| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $137.7M | -1.0% |
| Cost of Revenue | $28.4M | +6.0% |
| R&D Expense | $11.5M | +9.5% |
| SG&A Expense | $33.3M | +0.4% |
| Operating Income | $19.0M | -10.7% |
| Pre-tax Income | $20.0M | -10.3% |
| Income Tax | $5.1M | -23.9% |
| Net Income | $15.0M | -4.5% |
| EPS (Basic) | $0.74 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.1M | -8.9% |
| Accounts Receivable | $21.9M | -5.9% |
| Current Assets | $61.3M | -4.1% |
| Total Assets | $217.1M | -4.6% |
| Current Liabilities | $48.8M | +1.6% |
| Total Liabilities | $62.4M | -2.4% |
| Stockholders' Equity | $154.7M | -5.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $28.9M | +10.5% |
| Capital Expenditures | $3.2M | -6.1% |
| Investing Cash Flow | -$3.2M | +6.1% |
| Financing Cash Flow | -$28.5M | -7.0% |
| Free Cash Flow | $25.7M | +12.9% |
| -6.3% |
| EPS (Diluted) | $0.73 | -5.2% |